cancer therapy
New CMS Payment Model Encourages Use of Novel Cancer Therapies
CMS implemented the five-year Enhancing Oncology Model to help more patients access novel cancer therapies at an ...
SEPTEMBER 29, 2023
Generics May Not Mean Big Savings in Specialty
It usually takes more than one generic in a specialty marketplace to drive down prices, experts said.
MAY 9, 2018
FDA Grants New Indication for Rubraca
The FDA granted a new indication for Rubraca for the maintenance treatment of recurrent ovarian, fallopian tube or ...
APRIL 6, 2018
Load more